Torbjörn Tomson, Tomas Andersson, Sofia Carlsson, Olafur Sveinsson
{"title":"Influence of Risk Factor Combinations on Incidence Rates of SUDEP: A Population-Based Study.","authors":"Torbjörn Tomson, Tomas Andersson, Sofia Carlsson, Olafur Sveinsson","doi":"10.1212/WNL.0000000000213372","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>Information on absolute risks of sudden unexpected death in epilepsy (SUDEP) in individual patients with epilepsy is scarce. Our main objective was therefore to explore the range in incidence rates of SUDEP to provide a more solid basis for individualized counseling and to characterize patients with high and very high SUDEP incidence for future intervention studies aiming at prevention of SUDEP.</p><p><strong>Methods: </strong>We used data on everyone in Sweden diagnosed with epilepsy from 1998 to 2005 (n = 60,952), followed until 2011 and identified SUDEP cases through adjudication of deceased patients who had epilepsy. We conducted a nested case-control study and retrieved detailed information on clinical characteristics for the SUDEP cases and matched living epilepsy controls (5:1). Estimates of the strengths of associations from the case-control study were used to estimate the incidence rate of SUDEP (per 100,000 person-years) in the full cohort by SUDEP risk factors.</p><p><strong>Results: </strong>Two hundred fifty-five SUDEP cases (median age 48 years; 154 males) were identified. The lowest incidence, 8 (95% CI 3-17), was observed among patients without a history of tonic-clonic seizures (TCS), whereas patients with 1 or more TCS the preceding year had an incidence of 287 (95% CI 192-428). Incidence rates above 200 were also found among patients with a history of nocturnal TCS, substance abuse or alcohol dependence, and nonadherence with antiseizure medication (ASM) treatment. Considering combination of risk factors, the incidence rate was very low, 5 (95% CI 2-12), for patients who share bedroom and are free from TCS the preceding year as well as adherent with the prescribed ASM treatment. By contrast, patients living alone who are nonadherent have a history of nocturnal TCS and at least 1 TCS the preceding year have an incidence at 1808 (95% CI 594-5,504), more than 350 times higher than the low-risk patient.</p><p><strong>Discussion: </strong>In this analysis of Swedish population-based SUDEP data, we have identified a 350-fold difference in the SUDEP incidence depending on individual circumstances and epilepsy characteristics. Although somewhat old, our data should be useful for patient counseling about individual SUDEP risks amenable to modification and for case stratifications for intervention studies aiming at prevention of SUDEP.</p>","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"104 5","pages":"e213372"},"PeriodicalIF":8.5000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/WNL.0000000000213372","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objective: Information on absolute risks of sudden unexpected death in epilepsy (SUDEP) in individual patients with epilepsy is scarce. Our main objective was therefore to explore the range in incidence rates of SUDEP to provide a more solid basis for individualized counseling and to characterize patients with high and very high SUDEP incidence for future intervention studies aiming at prevention of SUDEP.
Methods: We used data on everyone in Sweden diagnosed with epilepsy from 1998 to 2005 (n = 60,952), followed until 2011 and identified SUDEP cases through adjudication of deceased patients who had epilepsy. We conducted a nested case-control study and retrieved detailed information on clinical characteristics for the SUDEP cases and matched living epilepsy controls (5:1). Estimates of the strengths of associations from the case-control study were used to estimate the incidence rate of SUDEP (per 100,000 person-years) in the full cohort by SUDEP risk factors.
Results: Two hundred fifty-five SUDEP cases (median age 48 years; 154 males) were identified. The lowest incidence, 8 (95% CI 3-17), was observed among patients without a history of tonic-clonic seizures (TCS), whereas patients with 1 or more TCS the preceding year had an incidence of 287 (95% CI 192-428). Incidence rates above 200 were also found among patients with a history of nocturnal TCS, substance abuse or alcohol dependence, and nonadherence with antiseizure medication (ASM) treatment. Considering combination of risk factors, the incidence rate was very low, 5 (95% CI 2-12), for patients who share bedroom and are free from TCS the preceding year as well as adherent with the prescribed ASM treatment. By contrast, patients living alone who are nonadherent have a history of nocturnal TCS and at least 1 TCS the preceding year have an incidence at 1808 (95% CI 594-5,504), more than 350 times higher than the low-risk patient.
Discussion: In this analysis of Swedish population-based SUDEP data, we have identified a 350-fold difference in the SUDEP incidence depending on individual circumstances and epilepsy characteristics. Although somewhat old, our data should be useful for patient counseling about individual SUDEP risks amenable to modification and for case stratifications for intervention studies aiming at prevention of SUDEP.
背景和目的:关于个体癫痫患者癫痫猝死(SUDEP)绝对风险的信息很少。因此,我们的主要目的是探索SUDEP的发病率范围,为个性化咨询提供更坚实的基础,并为未来旨在预防SUDEP的干预研究提供高发病率和极高发病率患者的特征。方法:我们使用1998年至2005年瑞典所有癫痫患者的数据(n = 60,952),随访至2011年,并通过判定已死亡的癫痫患者来确定SUDEP病例。我们进行了一项巢式病例对照研究,检索了SUDEP病例的临床特征和匹配的活癫痫对照(5:1)的详细信息。病例对照研究的关联强度估计值用于根据SUDEP危险因素估计全队列中SUDEP的发病率(每100,000人年)。结果:SUDEP病例255例(中位年龄48岁;154名男性)。在没有强直-阵挛发作(TCS)病史的患者中,发病率最低,为8 (95% CI 3-17),而前一年有一次或多次TCS的患者发病率为287 (95% CI 192-428)。在有夜间TCS病史、药物滥用或酒精依赖、抗癫痫药物治疗不依从的患者中,发病率也高于200。综合考虑危险因素,对于共用卧室、前一年未发生TCS并坚持规定的ASM治疗的患者,发病率非常低,5 (95% CI 2-12)。相比之下,非依从性独居患者有夜间TCS病史且前一年至少有1次TCS,其发生率为1808 (95% CI 594- 5504),比低危患者高350倍以上。讨论:在瑞典基于人群的SUDEP数据分析中,我们发现根据个体情况和癫痫特征,SUDEP发病率存在350倍的差异。虽然有些陈旧,但我们的数据应该对患者关于个体SUDEP风险可修改的咨询和针对预防SUDEP的干预研究的病例分层有用。
期刊介绍:
Neurology, the official journal of the American Academy of Neurology, aspires to be the premier peer-reviewed journal for clinical neurology research. Its mission is to publish exceptional peer-reviewed original research articles, editorials, and reviews to improve patient care, education, clinical research, and professionalism in neurology.
As the leading clinical neurology journal worldwide, Neurology targets physicians specializing in nervous system diseases and conditions. It aims to advance the field by presenting new basic and clinical research that influences neurological practice. The journal is a leading source of cutting-edge, peer-reviewed information for the neurology community worldwide. Editorial content includes Research, Clinical/Scientific Notes, Views, Historical Neurology, NeuroImages, Humanities, Letters, and position papers from the American Academy of Neurology. The online version is considered the definitive version, encompassing all available content.
Neurology is indexed in prestigious databases such as MEDLINE/PubMed, Embase, Scopus, Biological Abstracts®, PsycINFO®, Current Contents®, Web of Science®, CrossRef, and Google Scholar.